STAT

FEBRUARY 3, 2024

Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes. Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as par

Documentation 359

Documentation 359

Drug Patent Watch

FEBRUARY 3, 2024

NATESTO (testosterone) Acerus Patent: 8,877,230 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of February 4, 2024 appeared first on DrugPatentWatch - Make Better Decisions.

64

64

PharmaState Academy

FEBRUARY 3, 2024

???????????: To be awarded with 3CPhE (Continuing Pharma Education) points. Registration Open! Interest Form For Next Batch We limit the number of participants in a batch so that high-quality interactive learning can happen. In case you have missed this batch, you can fill out the Interest form for the next batch. We will send you the information, once the registrations open for the next batch.

Communication 59

Communication 59

Drug Patent Watch

FEBRUARY 3, 2024

Annual Drug Patent Expirations for NATESTO Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting… The post New patent expiration for Acerus drug NATESTO appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

RX Note

FEBRUARY 3, 2024

Introduction Dispensing separation is a critical policy that separates the roles of prescribing to physicians and dispensing to pharmacists. Under this policy, community pharmacists can act as a safety net, identifying and preventing medication errors and interactions, ultimately leading to improved healthcare outcomes. History In Malaysia, the Poisons Act 1952 (and its subsequent 1989 amendment) granted dispensing rights to both doctors and pharmacists due to a historical shortage of pharmacist

Community Pharmacies 40

Community Pharmacies Dosage Hospitals 40

Drug Patent Watch

FEBRUARY 3, 2024

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent expiration for Sumitomo Pharma drug ORGOVYX appeared first on DrugPatentWatch - Make Better Decisions.

59

59

PharmaTech

FEBRUARY 3, 2024

ProductLife Group has announced its acquisition of Australian company Commercial Eyes.

52

52

Drug Patent Watch

FEBRUARY 3, 2024

This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Portugal? appeared first on DrugPatentWatch - Make Better Decisions.

59

59